rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Weiss Asset Management LP

Other role

Company insider

Files Form 4 as: Other, Theravance Biopharma; Other, Avadel Pharmaceuticals; 10% owner, Marquee Raine Acquisition; 10% owner, Forum Markets; 10% owner, KLR Energy Acquisition; 10% owner, GlobalOptions Group; 10% owner, BBV Vietnam S.E.A. Acquisition; 10% owner, Spring Creek Acquisition.

In numbers

Trades disclosed
14
Buys
4
Sells
6
Bought
$1.1M
Sold
$247.3M
Companies
8
Companies where not an officer
8
First trade
14 Jan 2009
Last trade
23 Sep 2026
Last filed
28 Sep 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
Theravance BiopharmaOther · Pharmaceuticals · last 23 Sep 20260 buys · 0 sells
Avadel PharmaceuticalsOther · Biotechnology · last 13 Feb 20260 buys · 1 sell
Marquee Raine Acquisition10% owner · last 14 May 20210 buys · 1 sell
FRMM Forum Markets10% owner · Consumer & Specialty Finance · last 5 Jun 20190 buys · 0 sells
KLR Energy Acquisition10% owner · last 1 Jul 20160 buys · 1 sell
GlobalOptions Group10% owner · last 26 May 20113 buys · 1 sell
BBV Vietnam S.E.A. Acquisition10% owner · last 29 Jan 20090 buys · 2 sells
Spring Creek Acquisition10% owner · last 14 Jan 20091 buy · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
10Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
23 Sep 2026filed 28 Sep 2026Theravance BiopharmaPharmaceuticalsSEC FORM 4 Code J$126.8M7,457,060 at $17.00filing
23 Sep 2026filed 28 Sep 2026Theravance BiopharmaPharmaceuticalsSEC FORM 4 Code J$126.8M7,457,060 at $17.00filing
13 Feb 2026filed 18 Feb 2026Avadel PharmaceuticalsBiotechnologySEC FORM 4 Sold$233.4M11,112,052 at $21.00filing
14 May 2021filed 17 May 2021Marquee Raine AcquisitionSEC FORM 4 Sold$1.5M150,000 at $9.86filing
5 Jun 2019filed 7 Jun 2019FRMM Forum MarketsConsumer & Specialty FinanceSEC FORM 4 Code J$3.2M310,000 at $10.42filing
1 Jul 2016filed 6 Jul 2016KLR Energy AcquisitionSEC FORM 4 Sold$100K10,000 at $10.00filing
26 May 2011filed 27 May 2011GlobalOptions GroupSEC FORM 4 Sold$11.7M4,511,988 at $2.60filing
11 Jan 2011filed 13 Jan 2011GlobalOptions GroupSEC FORM 4 Bought$65K26,073 at $2.50filing
27 Oct 2010filed 1 Nov 2010GlobalOptions GroupSEC FORM 4 Bought$312K135,586 at $2.30filing
27 Oct 2010filed 29 Oct 2010GlobalOptions GroupSEC FORM 4 Bought$312K135,586 at $2.30filing
29 Jan 2009filed 2 Feb 2009BBV Vietnam S.E.A. AcquisitionSEC FORM 4 Sold$648K89,375 at $7.25filing
28 Jan 2009filed 30 Jan 2009BBV Vietnam S.E.A. AcquisitionSEC FORM 4 Sold$4,350600 at $7.25filing
14 Jan 2009filed 16 Jan 2009Spring Creek AcquisitionSEC FORM 4 Bought$338K50,000 at $6.75filing
14 Jan 2009filed 16 Jan 2009Spring Creek AcquisitionSEC FORM 4 Bought$95K14,000 at $6.81filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care1
Not placed9

Buys in green, sells in red, by the company’s sector.

Related people

Dean J. MitchellDirector · Director at Theravance Biopharma, filing Form 4 there in the last year
Deepika PakianathanDirector · Director at Theravance Biopharma, filing Form 4 there in the last year
Rick E. WinninghamChief Executive Officer · Chief Executive Officer at Theravance Biopharma, filing Form 4 there in the last year
Alsup Laurie SmaldoneDirector · Director at Theravance Biopharma, filing Form 4 there in the last year
Donal O'ConnorDirector · Director at Theravance Biopharma, filing Form 4 there in the last year